Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
03. September 2024 07:00 ET
|
Amphista Therapeutics
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer The appointment will accelerate the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein...
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
03. September 2024 03:00 ET
|
Amphista Therapeutics
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer The appointment will accelerate the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein...